CoChat
Sign Up
Cited by 149Multiple Sclerosis Research StudiesGastrointestinal motility and disordersGut microbiota and health

Fecal Microbiota Transplantation (FMT) in Multiple Sclerosis (MS): 942

Borody, Thomas, Leis, Sharyn, Campbell, Jordana, Torres, Margaux, Nowak, Anna·2011·American Journal of Gastroenterology
DOI 10.14309/00000434-201110002-00942
Open this paper in CoChat — free account

Abstract

Purpose: Recent evidence implicates the GI microbiota in the progression of neurological diseases such as Parkinsons Disease1, Multiple Sclerosis and Myasthenia Gravis2. We report three patients with MS diagnoses who achieved durable symptom reversal with FMT for constipation. Methods: Case study observations on three MS cases Results: Case 1: A 30 yr old male with constipation, vertigo and impaired concentration and a concomitant history of MS and trigeminal neuralgia. Neurological symptoms included severe leg weakness and he required a wheelchair and an indwelling urinary catheter. Previous failed treatments included Mexiletine, Tryptanol and β-interferon. The patient underwent 5 FMT infusions for his constipation, with its complete resolution. Interestingly his MS also progressively improved, regaining the ability to walk and facilitating the removal of his catheter. Initially seen as a ‘remission', the patient remains well 15 yrs post-FMT without relapse. Case 2: A 29 yr old wheelchair-bound male with ‘atypical MS' diagnosis and severe, chronic constipation. He reported parasthesia and leg muscle weakness. The patient received 10 days of FMT infusions which resolved his constipation. He also noted progressive improvement in neurological symptoms, regaining the ability to walk following slow resolution of leg parasthesia. Three years on the patient maintains normal motor, urinary and GI function. Case 3: An 80 yr old female presented with severe chronic constipation, proctalgia fugax and severe muscular weakness resulting in difficulty walking, diagnosed as ‘atypical' MS. She received 5 FMT infusions with rapid improvement of constipation and increased energy levels. At eight months she reported complete resolution of bowel symptoms and neurological improvement, now walking long distances unassisted. Two years post-FMT, the patient was asymptomatic. Conclusion: We report reversal of major neurological symptoms in three patients after FMT for their underlying GI symptoms. As MS can follow a relapsing-remitting course, this unexpected discovery was not reported until considerable time had passed to confirm prolonged remission. It is tempting to speculate that FMT achieved eradication of an occult GI pathogen driving MS symptoms. Our finding that FMT can reverse MS-like symptoms suggests a GI infection underpinning these disorders. It is hoped that such serendipitous findings may encourage a new direction in neurological research.

Integrity signals

Registry

Crossref · 10.14309/00000434-201110002-00942

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Fecal microbiota transplantation in three multiple sclerosis patients to treat severe constipation reverted the intestinal illness and improved multiple sclerosis symptoms.

    “In an additional relevant study, three MS patients underwent multiple fecal microbiota transplantations (FMT) to treat severe constipation. This treatment reverted the intestinal illness and improved the MS symptoms (147), proving the existence of a gut-brain connection.”

    From The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology (2020) · cites this paper as [147]

Cited by

Sorted by citations

Related

Authors
Borody, T., Leis, S., Campbell, J., Torres, M., & Nowak, A.
Affiliations
Centre For Digestive Diseases (AU)
ORCID
Venue
American Journal of Gastroenterology
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2011-10
Volume
106
Pages
S352
ISSN
0002-9270 (ISSN-L)
DOI
10.14309/00000434-201110002-00942
OpenAlex
W2978324930
Cited by
149
References
0
Citations by year
2026: 1 · 2025: 5 · 2024: 11 · 2023: 17 · 2022: 15 · 2021: 22 · 2020: 14 · 2019: 7 · 2018: 8 · 2017: 16 · 2016: 9 · 2015: 7 · 2014: 5 · 2013: 9 · 2012: 2
FWCI
3.81
Type
journal article
Language
en
Open access
closed
Locations
The American Journal of Gastroenterology (publishedVersion)
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords
fecal microbiota transplantation, multiple sclerosis, chronic constipation, proctalgia fugax, gut microbiota, urinary catheter removal, relapsing-remitting multiple sclerosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review